REGENXBIO (RGNX)
(Delayed Data from NSDQ)
$16.04 USD
+0.14 (0.88%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | -1.28 |
EPS Last Quarter | -1.43 |
Last EPS Surprise | -12.60% |
ABR | 1.31 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.98 |
Next Year | -3.28 |
EPS (TTM) | -6.03 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 25.10M | 25.57M | 146.66M | 164.92M |
# of Estimates | 5 | 5 | 7 | 6 |
High Estimate | 34.70M | 34.70M | 284.76M | 241.00M |
Low Estimate | 20.00M | 20.00M | 80.00M | 80.00M |
Year ago Sales | 19.14M | 19.98M | 90.24M | 146.66M |
Year over Year Growth Est. | 31.15% | 27.96% | 62.52% | 12.45% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.28 | -1.25 | -3.98 | -3.28 |
# of Estimates | 5 | 5 | 8 | 7 |
Most Recent Consensus | -1.50 | -1.40 | -3.58 | -5.15 |
High Estimate | -1.11 | -1.11 | -0.63 | -1.15 |
Low Estimate | -1.50 | -1.40 | -5.66 | -5.15 |
Year ago EPS | -1.53 | -1.66 | -6.02 | -3.98 |
Year over Year Growth Est. | 16.34% | 24.70% | 33.89% | 17.62% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.28 | -1.25 | -3.98 | -3.28 |
7 Days Ago | -1.28 | -1.25 | -3.98 | -3.28 |
30 Days Ago | -1.28 | -1.25 | -3.98 | -3.28 |
60 Days Ago | -1.21 | -1.22 | -2.83 | -3.05 |
90 Days Ago | -1.18 | -1.15 | -2.46 | -3.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.28 | -1.25 | -3.98 | -3.28 |
Zacks Consensus Estimate | -1.28 | -1.25 | -3.98 | -3.28 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.43 | -1.41 | -1.66 | -1.53 | NA |
Estimate | -1.27 | -1.44 | -1.26 | -1.52 | NA |
Difference | -0.16 | 0.03 | -0.40 | -0.01 | -0.14 |
Surprise | -12.60% | 2.08% | -31.75% | -0.66% | -10.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more